However, almost four in ten adults and a quarter of children with Medicaid have obesity, meaning expanding Medicaid coverage of these drugs could provide access to effective obesity treatments for millions
Theres no official list of retatrutide side effects yet, because it isnt approved
Firstly, reliance on diagnostic codes for disease classification might have resulted in an underrepresentation of mild cases, potentially leading to ascertainment bias
"*" indicates required fields For a quicker response or to book an upcoming appointment, please call (386) 293-1575
The ADA recommends nonsteroidal MRA (finerenone) for stage C heart failure with EF above 40% and for CKD protection alongside SGLT-2i
Weight loss : While not the original purpose of these medications, many patients experience significant and sustained weight lossespecially those on higher-dose versions like Wegovy or Zepbound